Rehn V, Yang Y, Bähre H , von der Ohe J, Hass R. Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells. Cancers (Basel). 2019; 11:
Bauersachs J, Thum T, Sedding DG. Senescence-induced inflammation: An important player and key therapeutic target in atherosclerosis. Eur Heart J. 2020. https://pubmed.ncbi.nlm.nih.gov/31898722 Tongers
(WSG) reports first data from the WSG-ADAPT trial (RunIn phase) for HR+/HER2- breast cancer in Therapeutic advances in medical oncology : https://pubmed.ncbi.nlm.nih.gov/33281950/ (Nov 2020) Our study on
(2024). Polysialic acid-Siglec immune checkpoints of microglia and macrophages: perspectives for therapeutic intervention. Neural Regen Res. 2024 Dec 16. doi: 10.4103/NRR.NRR-D-24-01195. Online ahead of print
R., Koenecke, C., & Schultze-Florey, C. R. (2022). Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML [...] Oncol. 2012 Jul 10;30(20):2475-82. Epub 2012 May 14. PubMed PMID: 22585692. Prinz I, Koenecke C. Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host
032485. Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease Kar S, Perrelli A, Bali KK, Mastrocola R, Kar
Gomis A, Wegner F, Viejo-Borbolla A. Stem Cell Res 2021;56:102535 DOI: 10.1016/j.scr.2021.102535 Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. Yang T, Poenisch M, Khanal R, Hu Q
clinical concept and methodology. May M, Framke T, Junker B, Framme C, Pielen A , Schindler C. Therapeutic advances in endocrinology and metabolism 2019;10; Volltext: https://doi.org/10.1177/2042018819891886 [...] B , Callizo J, EAGLE Study Group. Neuroradiology 2015;57(10):1055-1062 miR-145 is a promising therapeutic target to prevent cornea scarring. Ratuszny D, Gras C, Bajor A , Börger AK, Pielen A, Börgel M
tion Lymphoproliferative Disease after Solid Organ Transplantation: Characterization of a new therapeutic target. Leuk Lymphoma 2014; 1-10 Schubert S, Traub F , Brakensiek K, von Kopylow K, Marohn B, Maelzer
Armin , and Joachim Röhmel. 2002. “The Impact of Sloppy Study Conduct on Noninferiority Studies.” Therapeutic Innovation & Regulatory Science 36(1):3–6. doi: 10.1177/009286150203600102. Sillem, Martin, Sophia [...] Koch, Armin , and Joachim Röhmel. 2001. “Why Are Some Meta-Analyses More Credible than Others?” Therapeutic Innovation & Regulatory Science 35(3):1019–30. doi: 10.1177/009286150103500341. Koch, Armin , Sandra [...] Post-Transplant Lymphoproliferative Disease after Solid Organ Transplant: Characterization of a New Therapeutic Target.” Leukemia and Lymphoma 56(3):832–33. Behrens, Katharina, Melina A. Del Pozo, Anika Großhennig